History, Vision, Mission

MISSION
To integrate, educate, promote research and normalize cardiovascular interventionism in Latin America.

 

VISION
SOLACI will represent cardiovascular interventionism in Latin America: an active, transparent and dynamic organization of high impact on its members’ everyday life and high value for interventional cardiologists, the National societies and the industry.

 

HISTORY
In June 1993, a small group of Latin American interventional cardiologists gathered at the Cardiology Institute in Mexico, decided to create GLACI (Grupo Latinoamericano de Cardiólogos Intervencionistas) The Latin American Group of Interventional Cardiologists, a group of friends that reckoned the need to share experiences and knowledge, to contribute to the growth of our specialty in all Latin American countries.

 

In December 1994, the group held their first International Symposium at Calafate, in the South of Argentina; about one hundred interventional cardiologists from Latin America, USA, Europe and Asia, gathered in the vicinity of Perito Moreno glacier.

 

From that moment on, the group saw a fast growth, till in 1995 it turned into a Scientific Society, giving birth to SOLACI, the same year the first Congress was organized in Sao Paulo, Brazil.

 

SOLACI’s commitment to research and training resulted in increasingly important meetings and courses, the registry of interventions and procedures, research protocols, our web page, education and training grants, and continuous exchange between members.

 

The Society’s work has translated into a strong development of interventional cardiology in all countries of Latin America and the Caribbean.

 

Previous article
Next article

More articles by this author

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of registration for Module 2...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus release with two anticoagulant agents (rivaroxaban and...

Esta es una entrada en ingles

demo en ingles

test eng

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...